Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120,284,725
-
Total 13F shares
-
57,356,707
-
Share change
-
+42,172,226
-
Total reported value
-
$75,746,429
-
Put/Call ratio
-
35200%
-
Price per share
-
$1.32
-
Number of holders
-
60
-
Value change
-
+$55,507,141
-
Number of buys
-
38
-
Number of sells
-
15
Institutional Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q1 2024
As of 31 Mar 2024 IMMUNIC, INC. - Common Stock (IMUX) had 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 57,356,707 shares of stock of the company.
Largest 10 holders included Avidity Partners Management LP, BVF INC/IL, Soleus Capital Management, L.P., JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., RTW INVESTMENTS, LP, VANGUARD GROUP INC, Gratus Capital, LLC, Omega Fund Management, LLC, and Ikarian Capital, LLC.
This table shows 60 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.